Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

25.87
BATS BZX Real-Time Price
As of 9:51am ET
 -0.09 / -0.35%
Today’s Change
12.67
Today|||52-Week Range
37.81
+46.57%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close25.96
Today’s open25.65
Day’s range25.56 - 26.30
Volume38,794
Average volume (3 months)382,893
Market cap$910.1M
Dividend yield--
Data as of 9:38am ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+31.41%
Earnings growth (this year)-168.62%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.91%
P/E ratioNM
Price/Sales875.93
Price/Book6.35

Competitors

 Today’s
change
Today’s
% change
FLMLFlamel Technologies ...-0.25-1.11%
PDLIPDL BioPharma Inc-0.01-0.18%
MGNXMacroGenics Inc+0.15+0.57%
SUPNSupernus Pharmaceuti...+0.20+1.14%
Data as of 9:55am ET, 08/28/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$577.3K
Annual profit (last year)-$30.7M
Net profit margin-5,316.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers